SummaryDisclaimer: This paper is published under the sole responsibility of the authors and may not be considered as an EFSA output and is not intended to represent the views of EFSA. The paper is based on the annex of OECD (2012) The use of trade names is for identification only and does not constitute endorsement by the authors, EFSA, OECD, or the Albert Einstein College of Medicine. 1 Abbreviations BPA, bisphenol A; CG/CpG, cytosine-guanine dinucleotide; ChIP, chromatin immunoprecipitation; DNMT, DNA methyltransferase; ED, endocrine disruptor; EDTA-AG, OECD Endocrine Disruptor Testing and Assessment Advisory Group; ENCODE, ENCyclopedia Of DNA Elements; ES, embryonic stem; EZH2, enhancer of zeste homolog 2; IAP, intracisternal A particle; IUGR, intrauterine growth restriction; miRNA, micro RNA; MPS, massively-parallel sequencing; OECD, Organisation for Economic Cooperation and Development; TG, Test Guideline toxicology and safety assessment. At the research level, these efforts currently aim to elucidate the involvement of chemicalinduced epigenetic changes in adverse health effects, as well as to enable the exploitation of epigenetics particularly in the area of in vitro and in vivo modeling. While there have been plenty of reports linking endocrine disruptors with phenotypic abnormalities in wildlife, there are currently no publications describing epigenetic studies in wildlife undergoing these exposures.